Contact this trialFirst, we need to learn more about you.
Enzyme
Calaspargase + Cobimetinib for Pancreatic Cancer
Recruiting1 awardPhase 1
Portland, Oregon
This trial is testing the safety and best dose of two drugs to treat pancreatic cancer. One drug, calaspargase pegol-mknl, starves cancer cells of a nutrient they need. The other drug, cobimetinib, attacks a protein that stimulates cancer cell growth.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service